Article

Prodizen, the participation of the International Academy of Education Association...Show PRP technology

  • 작성일 : 2025.10.22
  • 조회수 : 39

9947bbb21282c30cf6c7aebb2c0af8a6_1762136842_4761.jpg
 

Prodizen, a regenerative medicine company, participated in the "2025 Korean Society of Aesthetic Plastic and Laser Medicine" (hereinafter referred to as "ASLS Korea 2025)" held at COEX in Seoul from October 11 to 12 to showcase innovative PRP KIT and GFC+ products.


The Damire Society is an academic event representing beauty medicine in Korea, and this year, 147 companies participated in 331 booths, and more than 7,000 people, including medical staff, researchers, and industry officials, visited, making it the largest ever. In addition, more than 2,000 medical staff from eight countries, including Japan, China, Taiwan, Singapore and Hong Kong, attended the event, establishing itself as a venue for international academic exchanges.

In this exhibition, Prodizen introduced a wide range of medical solutions related to cell regeneration and tissue recovery, focusing on 'GFC+', which is evaluated as a new standard of PRP technology. GFC+ is an innovative product that can be applied to various procedures such as improving skin elasticity, treating scars, pigment, and hair regeneration by extracting and activating growth factors in platelets at a high concentration. In addition, it is characterized by the implementation of uniform growth factor concentration, improved cell reactivity, and high safety by supplementing the shortcomings of existing PRP procedures, and has been proven effective and safe through a number of clinical data.

In this exhibition, Prodigen introduced a wide range of medical solutions related to cell regeneration and tissue recovery, focusing on 'GFC+', which is evaluated as a new standard of PRP technology. GFC+ is an innovative product that can be applied to various procedures such as improving skin elasticity, treating scars, pigment, and hair regeneration by extracting and activating growth factors in platelets at a high concentration. In addition, it is characterized by the implementation of uniform growth factor concentration, improved cell reactivity, and high safety by supplementing the shortcomings of existing PRP procedures, and has been proven effective and safe through a number of clinical data.

"The Damire Society is a global networking platform that presents the future direction of the beauty care industry beyond just exhibition events," a Prodizen official said. "Prodizen will continue to grow into a brand that provides safe and effective options for medical staff and patients through regenerative medicine solutions based on clinical data."

Prodizen, on the other hand, is a bio-specialized company that has focused on cell therapy and tissue regeneration engineering for more than 25 years since its inception in 1998. It developed and commercialized PRP tubes for the first time in Korea, and has been supplying products to medical sites for more than 10 years since 2008, carrying out a full-scale PRP business. Based on these research results, it has obtained European CE certification and US FDA approval, and is currently expanding exports to Asia, Europe, and North America.


Medical Today reporter Choi Min-seok (press@mdtoday.co.kr )